載入...
Addition of sitagliptin to ongoing metformin monotherapy improves glycemic control in Japanese patients with type 2 diabetes over 52 weeks
AIMS/INTRODUCTION: The efficacy and safety of sitagliptin, a highly selective dipeptidyl peptidase‐4 inhibitor, when added to metformin monotherapy was examined in Japanese patients with type 2 diabetes. MATERIALS AND METHODS: In this 52‐week, add‐on to metformin study, 149 patients were randomly as...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Wiley-Blackwell
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4019272/ https://ncbi.nlm.nih.gov/pubmed/24843649 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12001 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|